Naltrexone
Top View
- Potentiation of Low Dose Ketamine Effects by Naltrexone: Potential Implications for the Pharmacotherapy of Alcoholism
- Pharmacological Drugs Inducing Ototoxicity, Vestibular Symptoms and Tinnitus: a Reasoned and Updated Guide
- What Is Necessary and Sufficient to Provide Naltrexone Or Buprenorphine in Primary Care Settings?
- Clinical Policy: Morphine Sulfate/Naltrexone Extended- Release (Embeda)
- Overview of Medication Assisted Treatment Methadone, Buprenorphine and Naltrexone
- Medication: Naltrexone 1 Mg
- Opioid Antagonist (Naltrexone) Modulation of Cerebellar Development: Histological and Morphometric Studies
- Perioperative Considerations for the Patient with Opioid Use Disorder on Buprenorphine, Methadone, Or Naltrexone Maintenance Therapy
- Naltrexone-Buprenorphine Interactions: Effects on Cocaine Self-Administration Nancy K
- Efficacy Naltrexone Treatment Alcohol Dependence
- Opioid Treatment Programs and Related Federal Regulations
- Continuing Buprenorphine Or Naltrexone-Containing Drugs in Peri-Operative Patients
- Antagonists in the Medical Management of Opioid Use Disorders: Historical and Existing Treatment Strategies
- Low Dose Naltrexone Patient Information Sheet
- Vivitrol (Naltrexone for Extended-Release Injectable Suspension) Policy Number: C5775-A
- Your Pharmacist / Your Advocate
- Drug-Induced Endocrinopathies and Diabetes
- Prescribing Information